Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/2003
03/19/2003EP1293126A1 Ophthalmic solution and contact lens solution
03/19/2003EP1292712A1 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids
03/19/2003EP1292709A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
03/19/2003EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292681A1 Antigenic polypeptides
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292668A2 Gene disruption methodologies in fungi for drug target discovery
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292612A2 Glycopeptide phosphonate derivatives
03/19/2003EP1292609A2 Peptides, compositions and methods for the treatment of burkholderia cepacia
03/19/2003EP1292604A1 2-aminocarbonyl-9h-purine derivatives
03/19/2003EP1292603A2 Methods and compositions for treating hepatitis c virus
03/19/2003EP1292576A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/19/2003EP1292575A2 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
03/19/2003EP1292563A2 Compounds useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity
03/19/2003EP1292347A1 Drug delivery apparatus
03/19/2003EP1292333A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form
03/19/2003EP1292328A1 Chimeric human papillomavirus (hpv) l1 molecules and uses therefor
03/19/2003EP1292324A2 Critical illness neuropathy
03/19/2003EP1292322A1 Immunosuppressor agent derived from morbillivirus
03/19/2003EP1292314A2 Method for treating respiratory disorders associated with pulmonary elastic fiber injury comprising the use of glycosaminoglycans
03/19/2003EP1292313A2 Methods for treating hepatitis delta virus infection with beta-l-2' deoxy-nucleosides
03/19/2003EP1292310A1 Novel anti-infectives
03/19/2003EP1292298A1 Intracorporeal medicaments for high energy phototherapeutic treatment of disease
03/19/2003EP1292293A1 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
03/19/2003EP1292291A2 Use of c 4-c10 acids for preventing gram-negative bacterial infections
03/19/2003EP1292282A2 Improved injectable dispersions of propofol
03/19/2003EP1292279A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
03/19/2003EP1278528A4 Nucleoside analogs with carboxamidine-modified bicyclic base
03/19/2003EP1257281A4 Nucleoside analogs with carboxamidine modified monocyclic base
03/19/2003EP1178984B1 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/19/2003EP1177192B1 Antifungal ethers
03/19/2003EP1175148B1 Infection resistant polymers, their preparation and uses
03/19/2003EP1171176B1 Implant for recreating vertebrae and tubular bones
03/19/2003EP1107766B1 Use of lithium gluconate in the preparation of a medicament for treating herpes and seborrheic dermatitis
03/19/2003EP1060162B1 Urethanes derived from azacycloalkanes, thio and dithio analogues, production and use thereof as 2,3 epoxysqualene lanesterol cyclase inhibitors
03/19/2003EP0964697B1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
03/19/2003EP0888309B1 Imidazole derivatives having affinity for alpha2 receptors activity
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0874847B1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
03/19/2003EP0871490B1 Branched hydrazone linkers
03/19/2003EP0758245B1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori
03/19/2003EP0711350B1 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid
03/19/2003EP0595935B1 Papillomavirus Vaccine
03/19/2003EP0556333B1 Avirulent salmonella microbes comprising a mutation in the cdt gene and uses therefor
03/19/2003CN1404487A High purity lipopeptides, lipopeptide micelles, process for preparing same
03/19/2003CN1404484A Pluraflavins and derivatives thereof, process for their preparation and use thereof
03/19/2003CN1404481A Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of PDE4 isozymes
03/19/2003CN1404480A Pyrimidine carboxamides useful as inhibitors of PDE4 isozymes
03/19/2003CN1404468A Novel use of phenylheteroalkylamine derivatives
03/19/2003CN1404401A G-CSF conjugates
03/19/2003CN1404400A Use of IL-18 inhibitors
03/19/2003CN1404399A Novel non-antigenic mucosal adjuvant formulation for modulating the effects of substances, including vaccine antigens in contact with mucosal body surface
03/19/2003CN1404398A Improved DNA vaccines for production-type animals
03/19/2003CN1404395A Antiadhesive carbohydrates
03/19/2003CN1404392A Antiviral azaindole derivatives
03/19/2003CN1403574A Modified EB virus LMP1 coding sequence and its prepn and application
03/19/2003CN1403450A Prepn process and medicine composition of andrographolide derivatives
03/19/2003CN1403154A Application of Hepcidin in pharmacy
03/19/2003CN1403140A Medicine for treating acute and chronic hepatitis B
03/19/2003CN1403138A Compound Chinese medicine prepn for treating urinary system infection and prostatitis and its prepn process
03/19/2003CN1403134A Prepn of medicine for treating hepatosis
03/19/2003CN1403102A Effective cure for curing tuberculosis
03/19/2003CN1403085A Medicine for inhibiting and killing body's superficial pathogenic fungi
03/19/2003CN1403084A Ganciclovir injection and its production process
03/19/2003CN1103221C Medicine for treating HIV infections
03/19/2003CA2422816A1 Disinfectant agent
03/18/2003WO2002024712A1 Triazolo-epothilones
03/18/2003US6534660 CC-1065 analog synthesis
03/18/2003US6534544 Methods of treatment with compounds having RARα receptor specific or selective activity
03/18/2003US6534530 Administering (benzo)thiazole peptidomimetic as viricide; protease inhibitors
03/18/2003US6534523 Racemates, diastereoisomers and optical isomers of a compound of formula (I): synthesis, compositions and methods for the treatment of hepatitis C virus (HCV) infection and intermediates
03/18/2003US6534520 Antiviral compounds
03/18/2003US6534518 Polysubstituted 6-phenylphenanthridines with PDE-IV inhibiting activity
03/18/2003US6534508 Treatment of Mycobacteria infection by administering (S)-lomefloxacin or a pharmaceutically acceptable salt thereof free of its (R)-stereoisomer
03/18/2003US6534493 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
03/18/2003US6534489 Organophosphorus compounds and the use thereof
03/18/2003US6534483 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods
03/18/2003US6534482 Expression vectors for stimulating an immune response and methods of using the same
03/18/2003US6534478 Cyclic azapeptides with angiogenic effect
03/18/2003US6534310 Suppression of proteolytic activity by dysfunctional protease formation
03/18/2003US6534275 Isolated polypeptide having specified amino acid sequence or immunogenic fragment thereof
03/18/2003US6534261 Regulation of endogenous gene expression in cells using zinc finger proteins
03/18/2003US6534259 Regressive behavioral disorder diagnosis
03/18/2003US6534087 Process for preparing a pharmaceutical composition
03/18/2003US6534065 Influenza vaccine composition with chitosan adjuvant
03/18/2003US6534061 Isolated DNA98853 and DNA101848 polypeptides
03/18/2003US6534054 Probiotic/therapeutic uses of nonpathogenic probiobiotic microorganisms; manufacturing the formulation from the plant derived material
03/18/2003US6534053 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications
03/18/2003CA2678495A1 Disinfectant composition including quaternary ammonium salt and alkanolamine
03/18/2003CA2422500A1 Triazolo-epothilones
03/18/2003CA2362944C Optical isomers of ¬3-(1,1-dialkylated)-1-aminomethyl-pyrrolidine|
03/18/2003CA2263181C Anti-chlamydial methods and materials
03/18/2003CA2176840C Combination of an antimicrobial compound with a glycerol monoalkylether
03/18/2003CA2092519C Synthetic polypeptides as inhibitors of hiv-1
03/14/2003WO2003025166A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
03/14/2003CA2460377A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes
1 ... 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 ... 1798